|
|
|
|
| TRADING CENTER |
53.13-0.16 / -0.30%
Novartis AG (NYSE:NVS)
Prev. Close:
53.29
Open:
52.78
High:
53.23
Low:
52.75
Volume:
1,373,100
Volume Avg.:
1,421,400
52wk Range:
33.34 - 54.23
Market Cap (mil):
140,136.91
P/E Ratio:
14.92
Dividend Yield:
N/A
| Now Is the Time to Buy Risk - MotleyFool.com | |
| EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix - Dow Jones | |
| Pfizer Dodges a Bullet - MotleyFool.com | |
| Pfizer's Generic Growth, With a Side of Sashimi - MotleyFool.com | |
| Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc. - GlobeNewswire | |
| The Government Won't Be There for You - MotleyFool.com | |
| Dividends for 100 Years - MotleyFool.com | |
| 5-Star Stocks on the Upswing - MotleyFool.com | |
| Anti-Smoking Vaccine from Glaxo - Analyst Blog - Zacks.com | |
| This Partnership Is Smoking! - MotleyFool.com | |
| A Big Upgrade for Sanofi-Aventis - MotleyFool.com | |
| Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter ... - Zacks.com | |
| Glaxo H1N1 Vaccine Approved - Analyst Blog - Zacks.com | |
| AspenBio to Present at the Lazard Capital Market 6th Annual Healthcare Conference - Market Wire | |
| Gilead Awaits Committee Outcome - Analyst Blog - Zacks.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 62.31 | -0.12 / -0.19% | 13.60 |
| PFE | Pfizer Inc | 18.36 | 0.25 / 1.38% | 15.43 |
| RHHBY | Roche Hldg Ltd | 40.10 | 0.38 / 0.96% | n/a |
Short Interest Date:
Oct 30 2009
Short Interest Shares:
6,425,121
Short Interest Ratio:
3.9
Float:
n/a
Short Interest as a % of Float:
n/a
Average Daily Volume:
1,668,900
Outstanding Shares:
2,271,200,000
Novartis AG was incorporated on February 29, 1996 under the laws of Switzerland as a stock corporation. On December 20, 1996, the Company's predecessor companies, Ciba-Geigy and Sandoz, merged into this new entity, creating Novartis. The Company provides healthcare solutions that address the ... (more)
| 2008 Revenue: | $41.5 B | Headquarters: Basel, |
| Employees: | 96,717 | CEO: Dr. Daniel Vasella, M.D. |
| Net Income: | $8.2 B | Industry: Pharmaceuticals |
| Market Cap: | $120.3 B | Website: www.novartis.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| NVS | 53.13 | -0.16 / -0.30% | 53.29 | 53.23 | 52.75 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
